Breakthrough Supplement Triggers Self-Destruction in Prostate Cancer Cells
Originally Published 1 year ago — by Good News Network
Researchers at Cold Spring Harbor Laboratory have discovered that menadione, a precursor to vitamin K, can cause prostate cancer cells to self-destruct by interfering with their survival process. This finding, based on trials in mice, suggests that menadione could potentially be used to slow the progression of early-stage prostate cancer in men. The study highlights the potential of menadione as a novel treatment for aggressive and resistant forms of prostate cancer.
